GAVISCON
250MG/133,5MG/80MG TBL MND 6
Announcement of launch, break or close-out of marketing of a medicinal product:
https://prehledy.sukl.cz/mr.html?filtr=0241364All reports are available in the Overview.
250MG/133,5MG/80MG TBL MND 6
All reports are available in the Overview.
2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@suklcz.